Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas | Patent Number 08431163
US 08431163 B2Filled DateOct 15, 2012
Priority DateJun 30, 2009
Publication DateFeb 14, 2013
Expiration DateJun 29, 2029
Inventor/ApplicantsJames S. Baldassarre
Ralf Rosskamp
Ralf Rosskamp
ExaminesARNOLD, ERNST V
Art Unit1613
Technology Center1600
Assignments
Ikaria Therapeutics Llc
Current
Mallinckrodt Enterprises LlcCurrent
Mallinckrodt Holdings B.v.Current
Mallinckrodt International Finance S.a.Current
Imc Exploration CompanyCurrent
Lafayette Pharmaceuticals LlcCurrent
Mallinckrodt Cb LlcCurrent
Meh Inc.Current
Ludlow CorporationCurrent
Mallinckrodt Carribean Inc.Current
Mallinckrodt Pharmaceuticals IrelandCurrent
Ino Therapeutics MallinckrodtCurrent
Therakos Inc.Current
Vtesse Llc Fka Vtesse Inc.Current
Ocera Therapeutics Llc Fka Ocera Therapeutics Inc.Current
Mnk 2011 LlcCurrent
Mallinckrodt Veterinary Inc.Current
Stratatech CorporationCurrent
Specgx Llc MallinckrodtCurrent
Mallinckrodt Finance GmbhCurrent
Infacare Pharmaceutical CorporationCurrent
Cns Therapeutics Inc.Current
MallinckrodtCurrent
Sucampo Pharma LlcCurrent
St Shared Services LlcCurrent
Liebelflarsheim CompanyCurrent
Mallinckrodt Enterprises Holdings LlcCurrent
Ino Therapeutics MallinckrodtMallinckrodtOriginal
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge Program
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.